EFFICIENCY OF PHARMACOTHERAPY IN ALLERGIC RHINITIS, AS EVALUATED BY DECREASED CONCENTRATIONS OF FREE HEMOGLOBIN IN NASAL SECRETIONS
https://doi.org/10.15789/1563-0625-2006-5-6-689-696
Abstract
Abstract. Forty four patients with persistent allergic rhinitis and sensitization to the house dust mites were observed. All the patients have been examined in conformity with international diagnostic standards. The first group of observation included fifteen patients who received intranasal therapy by flutikasone propionate nasal spray at a dose of 200 mkg once a day for two weeks. The second group of observation included fourteen patients who received 10 inhalations of Affinoleukin® (a lyophilized complex of low molecular weight proteins from human leukocyte membranes with glycine), as aerosol, at a single dose of 2 units. Fifteen non-treated patients comprised a group of comparison. Eosinophil counts and concentrations of free hemoglobin (by immunometrical method in co-agglutination reaction) were made in nasal secretions twice (before treatment and two weeks later). It was found that the increase of free hemoglobin levels, as well as increase in eosinophil count in nasal secretions represents a symptom typical of exacerbation in persistent allergic rhinitis and reflects severity of disease. The therapy led to significant clinical improvement, decrease in free hemoglobin levels and eosinophil counts in nasal secretions, corresponding to clinical effect of both therapeutic modes of topical pharmacotherapy, resp., in 73% and 79% of the patients with persisting allergic rhinitis. Decrease in free hemoglobin level has allowed for the first time to reveal the immunotherapeutic efficiency of treatment with Affinoleukin® aerosol during exacerbations of persisting allergic rhinitis.
About the Authors
A. A. MokronosovaRussian Federation
Yu. I. Kochetova
Russian Federation
A. N. Matz
Russian Federation
References
1. Гущин И.С., Ильина Н.И., Польнер С.А. Аллергический ринит // Пособие для врачей. – М., 2002. – 72 с.
2. Диагностика и лечение аллергического ринита, и его влияние на астму // Руководство для врачей. Материалы отчета ARIA EAACI в сотрудничестве с ВОЗ. – М., 2001. – 24 с.
3. Дианова Д.Г. Иммунодиагностика и иммунокоррекция вторичных иммунодефицитов при вирусных заболеваниях глаз // Автореф. дисс. … канд. мед. наук. – Пермь, 2001. – 23 с.
4. Задионченко Е.В., Надгериева О.В., Мокроносова М.А., Знаменская Л.Ф., Яшин М.М., Трофимова И.Б. и Мац А.Н. Иммунотерапевтическая эффективность Аффинолейкина при атопическом дерматите // Биопрепараты. – 2004. – №4 (16). – С.25-31.
5. Кочетова Ю.И. Свободный гемоглобин в назальном секрете как диагностический маркер аллергического ринита // Автореф. дисс. … канд. мед. наук. – М, 2005. – 22 с.
6. Кочетова Ю.И., Мац А.Н., Мокроносова М.А. Определение концентрации свободного гемоглобина в назальном секрете у больных аллергическим и инфекционным ринитами // Российский аллергологический журнал. – 2004. – №3. – С.26-29.
7. Мац А.Н. Природа «трансфер-факторной» активности препарата Аффинолейкин // Биопрепараты. – 2004. – №4 (16). – С.7-13.
8. Мокроносова М.А., Кочетова Ю.И., Мац А.Н. Уровень свободного гемоглобина в назальном секрете в диагностике аллергического ринита // Аллергология. – 2004. – № 4. – С.24-27.
9. Пагнуева Л.Ю., Варфоломеева Е.В., Сперанская В.Н., Катаева Т.Н. Экспресс-метод определения скрытой крови // В сб.: Акт. вопросы вакцинно-сывороточного дела в XXI веке. – Пермь, 2003. – С.176-179.
10. Benson M., Strannegard I., Strannegard O., Wennergren G. Topical steroid treatment of allergic rhinitis decreases nasal fluid Th2 cytokines, eosinophils, eosinophil cationic protein and IgE, but has no effect on IFN-γ, IL-1β, TNF-α or neutrophils // J Allergy Clin Immunol. – 2000. – Vol.106 (2). – P.307-312.
11. Biedlingmaier J.F., Trifillis A. Comparison of CT scan and electron microscopic findings on endoscopically harvested middle turbinates // Otolaryngol Head Neck Surg. – 1998. – Vol.118. – P.165-173.
12. Cauwenberg P., Bachert C., Passalacqua G., Bousquet J., Canonica G.W., Durham S.R., Fokkens W.J., Howarth P.H., Lund V., Malling H.J., Mygind N., Passali D., Scadding G.K., Wang D.Y. Consensus statement on the treatment of allergic rhinitis // Allergy. – 2000. – Vol.55 (2). – P.116-134.
13. Conti F., Orlandini A. Trattamento di manifestazioni allergiche con Transfer Factor (TF) // La Med. Biol. – Aprile-Giugno, 1998. – P.35-39.
14. Dumonde D.C., Kirkpatrick C.H., Pizza G. Elevent International Congress on Transfer Factor // J.Interferon Cytokin Research. – 2000. – Vol.20. – P.439-441.
15. Groche D., Hoeno W., Hoss G., Vogt B., Herrmann Z, Witzigmann A. Standardization of two immunological HbA1c routine assays according to the new IFCC reference method // Clin Lab. – 2003. – Vol. 49 (11-12). – P. 657-661.
16. Holm A.F., Fokkens W.J., Godthelp T., Severijnen E.A., Mulder P.G., Vroom T.M., Rijntjes E. A 1- year placebo-controlled study of intranasal Fluticasone Propionate Aqueus Nasal Spray in patients with perennial allergic rhinitis: a safety and biopsy study // Clin. Otolaryngol. – 1998. – Vol.23. – P.69-73.
17. 4Life Transfer Factor Immune Spray – <https://transferfactorplus.my4life.com/?mod=store/store&gid=119>
18. Liu Xili. Treatment of allergic rhinitis with spleen transfer factor // Current Researches in Transfer Factor. Zou Zhao Fen, Huo Bao Lai (eds). China Science & Technology Press. – Beijing, 1993. – Р.239-243.
19. Lu Xiaolin, Ma Danjia, Xiong, Xiong Shiaobing. The Immunotherapy of Allergic Rhinitis // Research and Application of Transfer Factor and DLE. Huo Bao Lai, Wang Ru-zhang, Zou Zhao Fen (eds). Xueyuan Press. – Beijing, 1989. – P.366-374.
20. Lu Xiaolin., Yu Xiaolin., Gao Fulin. Treatment with OBS-TF in allergic rhinitis // Current Researches in Transfer Factor. Zou Zhao Fen, Huo Bao Lai (eds). China Science & Technology Press. – Beijing, 1993. – Р.232-238.
21. Meyer P., Persson C.G., Andersson M., Wollmer P., Linden M., Svensson C., Greiff L. Alpha-2-macroglobulin and eosinophil cationic protein in the allergic rhinitis // Eur Respir J. – 1999. – Vol. 13. – P.633-637.
22. Mygind N. Nasal allergy // London: Blackwell Scientific, 1979. – Vol.3. – P.38.
23. Ojeda M.O., van’t Veer C., Fernandez Ortega C.B., Arana Rosainz Mde J., Buurman W.A. Dialyzable leukocyte extract differentially regulates the production of TNFalpha, IL-6, and IL-8 in bacterial сompo-nentactivated leukocytes and endothelial cells // Inflamm Res. – 2005. – Vol. 54 (2). – P. 74-81.
24. Park Y.-J., Repka-Ramirez M., Naranch K., Velarde A., Clauw D., Baraniuk J.N. Nasal lavage concentrations of free hemoglobin as a marker of microepistaxis during nasal provocation testing // Allergy. – 2001. – Vol.57. – P.377-384.
25. Pekarek J., Eech K., and Barnet K. The clinical use of specific transfer factors. Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. // Maruzen Co., Ltd., Tokyo, 1991. – P. 256-263.
26. Rebulla P., Tedesco F., Radillo O., Battaglioli M., Boeri M., Rosso di San Secondo V.E., Sirchia G. Inhibition of in vitro adherence of antibody coated red cells to monocytes by the dialyzable leukocyte extract. // Transfusion. – 1991. – Vol. 31 (3). – P. 218-221.
27. Schwartz K.L., Monsur J.C., Bartoces M.G., West P.A., Neale A.V. Correlation of same-visit HbA1c test with laboratory-based measurements. A MetroNet study // BMC Family Practice, 2005. – Vol. 6. – P. 28.
28. Svensson C., Andersson M., Greiff L., Blychert L.O., Persson C.G. Exudative hyper responsiveness of the airway microcirculation in seasonal allergic rhinitis. // Clin Exp Allergy – 1995. – Vol. 5. – P. 942-950.
29. Wheaton Partners, Codemap 82274-QW: Blood, occult, by fecal hemoglobin determination by immunoassay, qualitative, feces, 1-3 simultaneous determination, CLIA waived test. – Barrington, USA, 2002.
Review
For citations:
Mokronosova A.A., Kochetova Yu.I., Matz A.N. EFFICIENCY OF PHARMACOTHERAPY IN ALLERGIC RHINITIS, AS EVALUATED BY DECREASED CONCENTRATIONS OF FREE HEMOGLOBIN IN NASAL SECRETIONS. Medical Immunology (Russia). 2006;8(5-6):689-696. (In Russ.) https://doi.org/10.15789/1563-0625-2006-5-6-689-696